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1. Introduction 
Imidazol is known to form complexes with liver 
alcohol dehydrogenase, which will stimulate inacti- 
vation and inhibition of the enzyme by several 
reagents [l-5] . Crystallographic studies have 
confirmed that one imidazol is bound per subunit 
[5]. The zinc atom at the catalytic centre has three 
protein ligands, cystelne-46, cysteine-174 and histi- 
dine-67 [6] . The fourth ligand is a water molecule/ 
hydroxyl ion, which can be replaced by imidazole 
[1,61. 
Specific modifications of the cysteine residues at 
the active centre in the horse liver enzyme or the 
related [7] yeast enzyme, have been performed with 
different reagents. Among them are iodoacetate [8,9] 
dibromoacetone [lo] and reactive coenzyme ana- 
logues [ 11,121. Specificity depends on the nature of 
the reagent and is influenced by other factors than just 
binding at the active site. In this context, cr-bromo- 
/3-(5imidazolyl) propionic acid (BIP) was considered 
to be of particular interest, since its imidazol group 
could be expected to bind specifically to the active 
site zinc atom. This would give a direct correlation 
between the primary binding site and the secondary 
chemical modification. BIP has been used previously 
to modify cysteine residues in papain [ 131. The rate 
of inactivation of liver alcohol dehydrogenase with 
BIP is not proportional to the inhibitor concentra- 
tion, but follows Michaelis-Menten type kinetics [ 141, 
again supporting specific binding of the reagent. 
The reaction of BIP with horse liver alcohol de- 
hydrogenase has therefore been studied in the present 
work, and the modified residue determined. The 
results show that only one residue, cysteine-46, is 
selectively modified in the reaction. 
2. Materials and methods 
Horse liver alcohol dehydrogenase was obtained 
from Boehringer Mannheim GmbH. The crystalline 
suspension was centrifuged, and the pellet dissolved in 
0.1 M NaaHP04, pH 9.0. The solution (10 mg/ml) was 
recentrifuged, and the supernatants dialyzed against 
six changes of phosphate buffer, pH 7.0,O.l I-(, 4°C 
and then used directly for the labelling experiments. 
Radioactive D,Lcr-bromo$(5-imidazolyl)-propionic 
acid ( [curboxy-14C] ), was prepared [ 151 by diazoti- 
zation of D,L-[curboxy-14C]-histidine obtained from 
New England Nuclear Chemicals GmbH. The product 
synthesized had a specific activity of 1.9 mCi/mmol. 
The reagent turned out to have the same mobility in 
thin-layer chromatography (Butanol/acetic acid/ 
water, 12:3:5, v/v/v) as the nonradioactive product 
(Pierce), and the value was exactly as that reported 
for BIP [15]. 
The labelled protein was studied after 50% and 
85% inactivation, respectively. The reaction was 
followed by activity measurements (25 4 samples) 
on a Gilford Model 2000 spectrophotometer [2], and 
stopped by addition of 10 mg cysteine. The labelled 
protein was dialyzed against three changes of phos- 
phate buffer, and one of water. 
The freeze-dried protein was carboxymethylated, 
for 4 h at 37°C (in 6 M Guanidine-HCl, 0.1 M Tris- 
HCl, 5 mM EDTA, pH 8.1) with iodoacetate at a ten- 
fold excess over the cysteine content of the enzyme. 
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Reagents were removed by dialysis against 10m3 M 
HCl. The protein was then digested with TLCK 
chymotrypsin (1% by weight) in 0.1 M ammonium 
bicarbonate, at 37°C for 4 h, under constant stirring. 
This treatment resulted in a soluble peptide mixture, 
which was lyophilized, and separated by exclusion 
chromatography on Sephadex G-50 (fine, 2.5 X 
100 cm) in 0.1 M ammonium bicarbonate. Radio- 
active fractions were pooled, and 14C-labelled 
peptides purified by high voltage electrophoresis and 
chromatography on paper [ 111, all steps being 
followed with autoradiography. Sequences were 
determined using the dansyl-Edman method, and 
amino acids with a Beckman 12 1 M Analyzer. 
3. Results 
3.1. Incorporation of [14C]BIP 
The irreversible inactivation of liver alcohol 
dehydrogenase with BIP is a pseudo first-order 
reaction. This is shown in fig.1. A 50% inactivation 
was reached after 90 min. Addition of cysteine 
stopped the reaction. This gave a radioactive protein 
with a specific activity of 2.1 mCi/mmoI, correspond- 
ing to 0.55 molecules of BIP per subunit. With 
different enzyme and inhibitor concentrations, 
another preparation reached 85% inactivation after 
180 mm. This gave a protein with a specific activity 
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Fig.1. Inactivation of horse liver alcohol dehydrogenase 
with [‘4C]BIP. The reaction was carried out in a 50 ml 
stopped glas flask at 23.5”C. Enzyme concentration was 
30 MM and BIP 520 PM. The reaction was stopped at the 
arrow by the addition of 10 mg cysteine. 
of 3 mCi/mmol, corresponding to about one molecule 
of BIP per subunit. 
3.2. Isolation of radioactive pep tides 
Exclusion chromatography of the chromatographic 
peptides gave one clear peak of radioactivity. This is 
shown in fig.2. Five fractions were pooled as indicated, 
and nearly all the radioactivity was accounted for by 
fractions II, III and IV, which contained 12, 28 and 
56%, respectively, of the original 14C-content of the 
protein. It is obvious that about 90% of the radio- 
activity is present in the peak corresponding to 
fractions III and IV. The radioactive peptides were 
Table 1 
Data for radioactive peptides from horse liver alcohol dehydrogenase labelled with [“Cl BIP 
Total composition B: Asp 2.0, Thr 1.7, Ser 2.1, Gly 2.2, Ala 1.2, Val 1.8a, Ile 0.7, Leu 1.0, His 0.9, Arg 0.9 
C: Asp 2.1, Thr 1.1, Ser 2.1, Gly 1.9, Val l.la, Ile 0.7, Leu 1.1, His 0.9, Arg 1.0 
Recovery B: 18% 
c: 33% 
Sequence 
41 45 M 50 55 57 
B: Val-Ala-ThrGly-Ile_C?s-A~-S~-Asp-Asp-His-Val-Val-Ser~ly-Thr-Leu -___\A-_----\ 
44 M 50 55 57 
C: G>-I&-C&Arr-Ser-Asp-Asp-His-Val-Val-Ser-Gly-Thr-Leu __._+~--~-- 
aRecovery of Val is low due to incomplete hydrolysis of the Val-Val bond in the amino acid sequence 
For total compositions, values given are molar ratios after hydrolysis in 6 M HCl, 1% phenol, at 110°C for 24 h. 
Recoveries are calculated from the radioactivities. For the sequence results, arrows (-) indicate residues analyzed 
by the dansyl-Edman method, and the positions in the primary structure of the protein are from [ 161. M denotes 
the label from BIP. 
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Fig.2. Exclusion chromatography of a chymotryptic digest of “C-1abelled horse liver alcohol dehydrogenase (120 mg) on 
Sephadex G-50 fine (2.5 X 100 cm) ln 0.1 M ammonium bicarbonate. Absorbance at 280 nm ( -) was monitored in a 
Unicam spectrophotometer, and radioactivity (. . . . . .) was measured in a Packard Tri-Carb liquid scintillation counter on 0.1 ml 
samples from every 5 ml. Fractions were pooled as indicated and separated by high-voltage paper electrophoresis at pH 6.5. 
Resulting autoradiographic pictures are also shown. Electrophoretic mobility is relative to aspartate [171. 
purified further on paper. In this way, three different 
peptides (A, B and’(Z) were obtained. Peptide A 
was the main radioactive peptide of fraction II, but 
was recovered in small amounts. Only about 2% of 
the r4C-content of this minor fraction was recovered, 
and therefore is not further considered. The other 
two peptides, B and C, were recovered in good yield 
from fractions III and IV, as shown in table 1. 
3.3. Identification of radioactive peptides 
Results of analysis for total composition and 
amino acid sequence of peptides B and C are given in 
table 1. The sequences how that the peptides are 
overlapping due to an incomplete sensitivity of a Thr- 
Gly bond to hydrolysis by chymotrypsin. The known 
primary structure of the protein [ 161 identifies the 
peptides as originating from positions 41-57 and 
44-57, respectively. Measurements of the radioactiv- 
ities of all extracts removed during the Edman degra- 
dations of peptide C showed a 15-fold increase in 
the “C-content corresponding to the third amino 
acid in the sequence. These results establish that the 
cysteine residue equivalent to cysteine46 (cf. table 1) 
is modified, explaining why it is not detected in the 
total composition (table 1). None of the other 
residues in the peptide was found to be labelled. 
Peptide data from the enzyme preparation 85% 
inactivated gave identical results. 
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The data show that labelling of cysteine-46 is 
specific and accounts for over 90% of the reagent 
incorporated into the protein. 
4. Discussion 
D,L-c+bromo-/3-(5imidazolyl) propionic acid is a 
specific reagent for modification of liver alcohol de- 
hydrogenase. The stoichiometry of BIP incorporation 
per subunit is in good agreement with the degree of 
inactivation obtained. Thus, on incorporation of 0.55 
molecules correspond to a 50% inactivation. The 
reaction is of the pseudo first-order and follows 
Michaelis-Menten type kinetics [ 141. Cysteine-46 is 
the only modified amino acid detected, with very 
little background labelhng. The modified cysteine 
seems to be chemically quite stable, and the label is 
not lost by decompositions during Edman degradations. 
This is in agreement with other observations [15] and 
in contrast to the lability of other labels that have 
beenused [11,12]. 
The results yield direct chemical support for the 
conclusions from kinetic and crystallographic studies 
showing that imidazole binds to the active site zinc 
atom [ 1,5] . Apparently, a reversible complex is first 
formed between BIP and the enzyme by imidazole- 
binding at the active site zinc atom, followed by an 
irreversible alkylation of cysteine-46. The tertiary 
structure of the enzyme also suggests that cysteine-46 
is more exposed to hydrophilic surroundings than the 
other cysteine residue at the active site, cysteine-174 
[5,6] . This is also in agreement with the present 
results, since the hydrophilic propionic acid part of 
BIP is probably oriented towards the hydrophilic 
anion binding site [S] of the active site region. Thus, 
labelling studies prove that BIP is a useful and specific 
reagent for chemical modification, and all data fit 
well with the three-dimensional structure of liver 
alcohol dehydrogenase. 
Acknowledgements 
A short term fellowship from EMBO ASTF 185 1 
to Knut Dahl made this work possible and is grate- 
fully acknowledged. The study was also supported by 
grants from the University of Oslo and from the 
Swedish Medical Research Council (project 13X-3532). 
References 
[l] Theorell, H. and McKinley-McKee, J. S. (1961) Acta 
Chem. Stand. 15,1811-1833. 
[2] Evans, N. and Rabin, B. R. (1968) Eur. J. Biochem. 4 
548-554. 
[ 31 Reynolds, C. H. and McKinley-McKee, J. S. (1969) Eur. 
J. Biochem. 10,474-478. 
[4] Reynolds, C. H., Morris, D. L. and McKinley-McKee, 
J. S. (1970) Eur. J. Biochem. 14, 14-26. 
[5] Zeppezauer, E., Jiirnvall, H. and Ohlsson, I. (1975) Eur. 
J. Biochem. 58, 95-104. 
[6] Eklund, H., Nordstrom, B., Zeppezauer, E., Soderlund, 
G., Ohlsson, I., Boiwe, T., Siiderberg, B.-O., Tapia, O., 
Brand&r, C.-l. and Akeson, A. (1976) J. Mol. Biol. 102, 
27-59. 
[7] Jornvall, H. (1976) Eur. J. Biochem., in press. 
[8] Harris, I. (1964) Nature (London), 203, 30-34. 
[9] Li, T.-K. and Vallee, B. L. (1964) Biochemistry 3, 
869-873. 
[lo] Dahl, K. H. and McKinley-McKee, J. S. (1976) Abstracts, 
Norwegian Biochem. Sot. Meeting p. 34. 
[ 1 l] Jornvall, H., Woenckhaus, C. and Johnscher, G. (1975) 
Eur. J. Biochem. 53,71-81. 
[ 121 Jornvall, H., Woenckhaus, C., Schittle, E. and Jeck, R. 
1131 
[I41 
1151 
(1975) FEBS Lett. 54,297-301. 
Jolley, C. J. and Yankeelov, Jr., J. A. (1972) 
Biochemistry 11, 1644169. 
Dahl, K. H. and McKinley-McKee, J. S. to be published. 
Yankeelov, Jr., J. A. and Jolley, C. J. (1972) Bio 
chemistry 11, 159-163. 
1161 Jornvall, H. (1970) Eur. J. Biochem. 16, 25-40. 
[I71 Offord, R. E. (1966) Nature (London), 211,591-593. 
290 
